DBV Technologies (DBVT) Enterprise Value (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Enterprise Value of -$174.9 million for Q2 2026, down 69.47% year-on-year from -$572.8 million in Q2 2025, and up 23.69% on a QoQ basis from -$229.2 million in Q1 2026.

DBV Technologies (DBVT) Enterprise Value (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Enterprise Value for 12 consecutive years, with -$174.9 million the latest figure, recorded in Q2 2026.

  • Quarterly Enterprise Value fell 69.47% year-over-year to -$174.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$174.9 million (down 69.47% YoY) and the FY2025 annual result came in at -$194.2 million, down 498.35% from the prior year.
  • Enterprise Value grew to -$174.9 million in Q2 2026 per DBVT's latest filing, from -$229.2 million in the prior quarter.
  • Over the last five years, Enterprise Value for DBVT reached as high as -$13.0 million in Q1 2025 and fell as low as -$248.0 million in Q2 2022.
  • A 5-year average of -$135.1 million and a median of -$145.3 million in 2023 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2025 — Enterprise Value soared 87.23% — and 2026, when it slumped 1668.25%.
  • Year by year, Enterprise Value stood at -$209.2 million in 2022, then soared by 32.42% to -$141.4 million in 2023, then surged by 77.04% to -$32.5 million in 2024, then slumped by 498.35% to -$194.2 million in 2025, then rose by 9.94% to -$174.9 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$174.9 million, -$229.2 million, and -$194.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -283.54 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - -32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -7.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -8.75 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -5.18 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -1.91 Bn
10 DBV Technologies 267.50 Mn 92.60 Mn - -174.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -174.90 Mn
Mar 31, 2026 -229.20 Mn
Dec 31, 2025 -194.20 Mn
Sep 30, 2025 -69.84 Mn
Jun 30, 2025 -103.21 Mn
Mar 31, 2025 -12.96 Mn
Dec 31, 2024 -32.46 Mn
Sep 30, 2024 -46.44 Mn
Jun 30, 2024 -66.21 Mn
Mar 31, 2024 -101.53 Mn
Dec 31, 2023 -141.37 Mn
Sep 30, 2023 -149.14 Mn
Jun 30, 2023 -173.96 Mn
Mar 31, 2023 -192.29 Mn
Dec 31, 2022 -209.19 Mn
Sep 30, 2022 -212.67 Mn
Jun 30, 2022 -247.97 Mn
Mar 31, 2022 -74.11 Mn
Dec 31, 2021 -77.30 Mn
Sep 30, 2021 -98.20 Mn